Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies
-
Published:2016-08
Issue:
Volume:168
Page:279-286
-
ISSN:0002-9394
-
Container-title:American Journal of Ophthalmology
-
language:en
-
Short-container-title:American Journal of Ophthalmology
Author:
Shen Elizabeth,
Rathinam Sivakumar R.,
Babu Manohar,
Kanakath AnuradhaORCID,
Thundikandy Radhika,
Lee Salena M.,
Browne Erica N.,
Porco Travis C.,
Acharya Nisha R.
Reference31 articles.
1. Vogt–Koyanagi–Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options;Silpa-archa;Autoimmun Rev,2016
2. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment;Du;Prog Retin Eye Res,2016
3. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease;Rao;Ophthalmology,2010
4. Vogt-Koyanagi-Harada syndrome. clinical course, therapy, and long-term visual outcome;Rubsamen;Arch Ophthalmol,1991
5. Prognostic factors for clinical outcomes in patients with vogt-koyanagi-harada disease treated with high-dose corticosteroids;Abu El-Asrar;Acta Ophthalmol,2013
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献